News & Events

Recently, Oxbridge Biotech Roundtable (OBR) interviewed Scientist’s Kevin Lustig about how his career decisions and approach to research shaped his...

Scientist’s Kevin Lustig recently blogged on mendelspod, explaining how the cost of drug development for pharmaceutical companies often leads to...

As 2012 comes to a close, we wanted to look back at the blog and provide a short review of the past year. To start, our top 3 most popular posts...

Over 9 months in the making, Scientist is proud to announce the immediate availability of our much improved Research Exchange platform. The...

Scientist has announced four winners for its first Tri-State Open Science Challenge: SAN DIEGO & NEW YORK — Scientist Inc., the world’s largest...

This past weekend, Scientist co-organized the Lab to Launch workshop with Biotech Acumen and OBR in San Diego, California to motivate and inspire...

The Early Drug Development Summit is happening this week in Berlin, Germany, and it brings early drug developers together to discuss maximizing...

Scientist is pleased to announce that it has been selected as a candidate for Red Herring’s 2012 Top 100 Global award, a prestigious recognition...

A Scientist user reminded me last week of Atul Butte’s TEDMED 2012 talk, which showcases Scientist’s outsourcing marketplace. While speaking about...

Scientist’s very own Kevin Lustig is one of the recipients of this year’s 2012 PharmaVOICE 100 award: Scientist is proud to announce that our own...